Suzanne J.K. Mund

Dr. Suzanne J.K. Mund

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2020 in Cells
Verified
Journal Article
Open access
PDF file
SMSuzanne J.K. Mund
Suzanne J.K. Mund
EKEiko Kawamura
Eiko Kawamura
AAAwang Hazmi Awang-Junaidi
Awang Hazmi Awang-Junaidi
JCJohn Campbell
John Campbell
BWBruce Wobeser
Bruce Wobeser
SBSpencer Barber
Spencer Barber
Limb wounds on horses are often slow to heal and are prone to developing exuberant granulation tissue (EGT) and close primarily through epithelialization, which results in a cosmetically inferior and non-durable repair. In contrast, wounds on the body heal rapidly and primarily through contraction and rarely develop EGT. Intravenous (IV) multipotent mesenchymal stromal cells (MSCs) are promising. They home and engraft to cutaneous wounds and promote healing in laboratory animals, but this has not been demonstrated in horses. Furthermore, the clinical safety of administering >1.00 × 108 allogeneic MSCs IV to a horse has not been determined. A proof-of-principle pilot project was performed with two horses that were administered 1.02 × 108 fluorescently labeled allogeneic cord blood-derived MSCs (CB-MSCs) following wound creation on the forelimb and thorax. Wounds and contralateral non-wounded skin were sequentially biopsied on days 0, 1, 2, 7, 14, and 33 and evaluated with confocal microscopy to determine presence of homing and engraftment. Results confirmed preferential homing and engraftment to wounds with persistence of CB-MSCs at 33 days following wound creation, without clinically adverse reactions to the infusion. The absence of overt adverse reactions allows further studies to determine effects of IV CB-MSCs on equine wound healing.

1 November 2021 in Cells
Verified
Journal Article
Open access
PDF file
SMSuzanne J.K. Mund
Suzanne J.K. Mund
DMDaniel J. MacPhee
Daniel J. MacPhee
JCJohn Campbell
John Campbell
Ali HonaramoozAli Honaramooz
Ali Honaramooz
BWBruce Wobeser
Bruce Wobeser
SBSpencer M. Barber
Spencer M. Barber
Limb wounds are common in horses and often develop complications. Intravenous multipotent mesenchymal stromal cell (MSC) therapy is promising but has risks associated with intravenous administration and unknown potential to improve cutaneous wound healing. The objectives were to determine the clinical safety of administering large numbers of allogeneic cord blood-derived MSCs intravenously, and if therapy causes clinically adverse reactions, accelerates wound closure, improves histologic healing, and alters mRNA expression of common wound cytokines. Wounds were created on the metacarpus of 12 horses. Treatment horses were administered 1.51–2.46 × 108 cells suspended in 50% HypoThermosol FRS, and control horses were administered 50% HypoThermosol FRS alone. Epithelialization, contraction, and wound closure rates were determined using planimetric analysis. Wounds were biopsied and evaluated for histologic healing characteristics and cytokine mRNA expression. Days until wound closure was also determined. The results indicate that 3/6 of treatment horses and 1/6 of control horses experienced minor transient reactions. Treatment did not accelerate wound closure or improve histologic healing. Treatment decreased wound size and decreased all measured cytokines except transforming growth factor-β3. MSC intravenous therapy has the potential to decrease limb wound size; however, further work is needed to understand the clinical relevance of adverse reactions.

25 May 2018 in Journal of Equine Veterinary Science
Verified
Journal Article
Closed access
PDF file
SMSuzanne J.K. Mund
Suzanne J.K. Mund
CCCharlotte Corbett
Charlotte Corbett
DMDaniel J. MacPhee
Daniel J. MacPhee
JCJohn Campbell
John Campbell
AHAli Honaramooz
Ali Honaramooz
SBSpencer M. Barber
Spencer M. Barber

12 October 2015 in Equine Veterinary Education
Verified
Journal Article
Closed access
PDF file
SMSuzanne J.K. Mund
Suzanne J.K. Mund